The combination of PP2 with AG9 or AG490 led to the induction of unspecific toxicity in CLL cells, making it impossible for assessing the additive effects of JAKs and Src inhibitors on IFN-mediated cell survival. Here, SRC is linked to B-cell chronic lymphocytic leukemia.